5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

 

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
I

Time Limited Therapy in CLL, Ibrutinib vs Zanubrutinib in WM & LOXO-305 in B-cell Malignancies

By 5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology FEATURING Ian W. Flinn
By 5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology FEATURING Ian W. Flinn
77 views
March 13, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Hematologic Malignancies
06:39

Frontline Therapy in CLL: Obinutuzumab + Ibrutinib, Ibrutinib vs. Ch…

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

I. Flinn

120 views
07:09

ELEVATE TN Data on Acalabrutinib - Practice Changing Trial in CLL

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

I. Flinn

228 views
11:47

Treatment Options for Newly Diagnosed Myeloma: Time to Incorporate C…

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

J. Berdeja

192 views
09:00

Treatment Options in R/R Multiple Myeloma: Tips for Selecting Among …

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

J. Berdeja

639 views
12:36

Future Directions in Multiple Myeloma: Selinexor Approval, Venetocla…

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

J. Berdeja

60 views
18:23

Time Limited Therapy in CLL, Ibrutinib vs Zanubrutinib in WM & LOXO-…

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

I. Flinn

77 views